HUE036963T2 - Eljárások, kompozíciók és készletek humán immundeficiencia vírus (HIV) meghatározásához - Google Patents

Eljárások, kompozíciók és készletek humán immundeficiencia vírus (HIV) meghatározásához

Info

Publication number: HUE036963T2
Authority: HU; Hungary
Prior art keywords: hiv; kits; compositions; methods; immunodeficiency virus
Prior art date: 2011-06-15

Application number

HUE12801310A

Other languages

English (en)

Inventor

Danuta Wronska

Katherine Schouest

Leslie Tremlett

Original Assignee

Grifols Therapeutics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-06-15

Filing date

2012-06-14

Publication date

2018-08-28

2012-06-14 Application filed by Grifols Therapeutics Inc filed Critical Grifols Therapeutics Inc

2018-08-28 Publication of HUE036963T2 publication Critical patent/HUE036963T2/hu

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
AIDS & HIV (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Analytical Chemistry (AREA)
Physics & Mathematics (AREA)
Microbiology (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Medicinal Chemistry (AREA)
Tropical Medicine & Parasitology (AREA)
Genetics & Genomics (AREA)
General Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
General Physics & Mathematics (AREA)
Food Science & Technology (AREA)
Cell Biology (AREA)
Pathology (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)

HUE12801310A 2011-06-15 2012-06-14 Eljárások, kompozíciók és készletek humán immundeficiencia vírus (HIV) meghatározásához HUE036963T2 (hu)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US201161497234P	2011-06-15	2011-06-15

Publications (1)

Publication Number	Publication Date
HUE036963T2 true HUE036963T2 (hu)	2018-08-28

Family

ID=47357719

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HUE12801310A HUE036963T2 (hu)	2011-06-15	2012-06-14	Eljárások, kompozíciók és készletek humán immundeficiencia vírus (HIV) meghatározásához

Country Status (14)

Country	Link
US (1)	US9273366B2 (hu)
EP (1)	EP2643460B1 (hu)
CN (1)	CN103635575B (hu)
AR (1)	AR086925A1 (hu)
AU (1)	AU2012271672B2 (hu)
BR (1)	BR112013032223A2 (hu)
ES (1)	ES2644839T3 (hu)
HU (1)	HUE036963T2 (hu)
MX (1)	MX340053B (hu)
PL (1)	PL2643460T3 (hu)
PT (1)	PT2643460T (hu)
RU (1)	RU2584573C2 (hu)
UY (1)	UY34128A (hu)
WO (1)	WO2012174187A2 (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US10113206B2 (en) *	2010-02-24	2018-10-30	Grifols Therapeutics Inc.	Methods, compositions, and kits for determining human immunodeficiency virus (HIV)
EP3191607B1 (en) *	2014-07-24	2019-08-21	Abbott Molecular Inc.	Compositions for the detection and analysis of mycobacterium tuberculosis
US10526664B2 (en)	2015-07-14	2020-01-07	Abbott Molecular Inc.	Compositions and methods for identifying drug resistant tuberculosis

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4458066A (en)	1980-02-29	1984-07-03	University Patents, Inc.	Process for preparing polynucleotides
US4415732A (en)	1981-03-27	1983-11-15	University Patents, Inc.	Phosphoramidite compounds and processes
US4605735A (en)	1983-02-14	1986-08-12	Wakunaga Seiyaku Kabushiki Kaisha	Oligonucleotide derivatives
US4757141A (en)	1985-08-26	1988-07-12	Applied Biosystems, Incorporated	Amino-derivatized phosphite and phosphate linking agents, phosphoramidite precursors, and useful conjugates thereof
US4826967A (en)	1987-06-16	1989-05-02	Naxcor	Psoralen-nucleoside adducts and method for their preparation
US5082934A (en)	1989-04-05	1992-01-21	Naxcor	Coumarin derivatives for use as nucleotide crosslinking reagents
CA2020958C (en)	1989-07-11	2005-01-11	Daniel L. Kacian	Nucleic acid sequence amplification methods
US5847096A (en) *	1991-08-30	1998-12-08	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	DNA constructs encoding CD4 fusion proteins
US6965020B2 (en)	1996-01-23	2005-11-15	Affymetrix, Inc.	Nucleic acid labeling compounds
CA2222769C (en) *	1997-01-17	2001-06-12	F. Hoffmann-La Roche Ag	Primers for the detection of hiv-1
US6534273B2 (en)	1997-05-02	2003-03-18	Gen-Probe Incorporated	Two-step hybridization and capture of a polynucleotide
CN1317009A (zh) *	1998-08-03	2001-10-10	东卡罗来纳大学	低腺苷反义寡核苷酸制剂、组合物、试剂盒及处理
RU2233844C2 (ru)	1999-02-12	2004-08-10	Санкио Компани Лимитед	Новые нуклеозидные и олигонуклеотидные аналоги
US20030027135A1 (en) *	2001-03-02	2003-02-06	Ecker David J.	Method for rapid detection and identification of bioagents
US20040121311A1 (en) *	2002-12-06	2004-06-24	Ecker David J.	Methods for rapid detection and identification of bioagents in livestock
EP1802772A4 (en) *	2004-09-10	2008-12-31	Sequenom Inc	METHOD FOR NUCLEIC ACID SEQUENCE ANALYSIS WITH GREAT RANGE
WO2007073149A1 (en) *	2005-12-22	2007-06-28	Keygene N.V.	Alternative nucleotides for improved targeted nucleotide exchange
KR20080037128A (ko)	2006-10-25	2008-04-30	주식회사 씨젠	뉴클레오타이드 변이 검출 방법
AU2009335688B2 (en) *	2008-12-19	2013-04-18	Abbott Laboratories	Molecular assay for diagnosis of HIV tropism

2012
- 2012-06-14 CN CN201280028651.0A patent/CN103635575B/zh not_active Expired - Fee Related
- 2012-06-14 AU AU2012271672A patent/AU2012271672B2/en not_active Ceased
- 2012-06-14 AR ARP120102105A patent/AR086925A1/es unknown
- 2012-06-14 UY UY0001034128A patent/UY34128A/es not_active Application Discontinuation
- 2012-06-14 WO PCT/US2012/042365 patent/WO2012174187A2/en active Application Filing
- 2012-06-14 HU HUE12801310A patent/HUE036963T2/hu unknown
- 2012-06-14 US US14/119,563 patent/US9273366B2/en active Active
- 2012-06-14 PT PT128013109T patent/PT2643460T/pt unknown
- 2012-06-14 MX MX2013013293A patent/MX340053B/es active IP Right Grant
- 2012-06-14 BR BR112013032223A patent/BR112013032223A2/pt not_active Application Discontinuation
- 2012-06-14 PL PL12801310T patent/PL2643460T3/pl unknown
- 2012-06-14 EP EP12801310.9A patent/EP2643460B1/en active Active
- 2012-06-14 ES ES12801310.9T patent/ES2644839T3/es active Active
- 2012-06-14 RU RU2013151821/10A patent/RU2584573C2/ru active

Also Published As

Publication number	Publication date
RU2013151821A (ru)	2015-05-27
WO2012174187A2 (en)	2012-12-20
BR112013032223A2 (pt)	2016-12-20
AU2012271672A1 (en)	2013-05-02
PT2643460T (pt)	2017-10-24
AR086925A1 (es)	2014-01-29
MX2013013293A (es)	2013-12-12
UY34128A (es)	2013-01-31
PL2643460T3 (pl)	2018-01-31
EP2643460A4 (en)	2014-05-21
AU2012271672B2 (en)	2016-02-18
US20140120526A1 (en)	2014-05-01
MX340053B (es)	2016-06-22
US9273366B2 (en)	2016-03-01
RU2584573C2 (ru)	2016-05-20
ES2644839T3 (es)	2017-11-30
EP2643460B1 (en)	2017-07-26
EP2643460A2 (en)	2013-10-02
WO2012174187A3 (en)	2013-03-28
CN103635575B (zh)	2019-03-01
CN103635575A (zh)	2014-03-12

Publication	Publication Date	Title
AU2016202543A1 (en)	2016-05-12	Human immunodeficiency virus (hiv)-neutralizing antibodies
PL3556396T3 (pl)	2022-09-12	Przeciwciała neutralizujące ludzki wirus niedoboru odporności (hiv)
HK1212935A1 (zh)	2016-06-24	廣譜中和抗抗體
EP2707025B8 (en)	2017-08-23	Hendra and nipah virus g glycoprotein immunogenic compositions
GB201115214D0 (en)	2011-10-19	Influenza virus antibody compositions
HK1200491A1 (en)	2015-08-07	Methods and compositions for regulating hiv infection hiv
SI3260136T1 (sl)	2021-05-31	Humani imunodeficientni virus (HIV)-nevtralizirajoča protitelesa
EP2763998A4 (en)	2014-09-17	TRI-HETEROCYCLIC DERIVATIVES, MANUFACTURING METHOD AND USES THEREOF
SG11201400236YA (en)	2014-03-28	Viral clearance methods
HK1200329A1 (en)	2015-08-07	Truncated hiv envelope proteins (env), methods and compositions related thereto hiv (env)
EP2738159A4 (en)	2015-06-03	MERCAPTO-BENZOPHENONE COMPOUNDS, COMPOSITIONS AND METHODS OF PREPARATION THEREOF
ZA201306419B (en)	2015-03-25	Compositions and methods for separating,characterizing and administering soluble selenoglycoproteins
IL228006A0 (en)	2013-09-30	Endodontic instruments, kits and methods for using endodontic instruments
WO2013052095A3 (en)	2013-06-06	Vaccine
EP2663327A4 (en)	2015-12-02	COMPOSITIONS AND METHOD FOR THE TREATMENT OF VIRUS INFECTIONS
EP2766183A4 (en)	2015-07-01	IRON FIBER COMPOSITION, PREPARATION THEREOF AND USES THEREOF
PT2643460T (pt)	2017-10-24	Métodos, composições e kits para determinação do virus da imunodeficiência humana (vih)
IL231494A0 (en)	2014-04-30	Lentiviral genome without chimeric integration as components against hiv-1
ZA201307019B (en)	2014-12-23	Compositions for preventing and/or treating and infection by an hiv-1 virus
WO2012139097A3 (en)	2013-01-17	Method of inducing neutralizing antibodies to human immunodeficiency virus
HK1195786A1 (zh)	2014-11-21	用於測定甲肝病毒的方法、組合物和試劑盒
AU2013369626A1 (en)	2015-06-25	Dengue virus vaccine composition
GB201005057D0 (en)	2010-05-12	HIV-1 ENV-deactivating alpha-bodies